223 related articles for article (PubMed ID: 26578351)
1. Propranolol Treatment of Cavernous Malformations with Symptomatic Hemorrhage.
Zabramski JM; Kalani MYS; Filippidis AS; Spetzler RF
World Neurosurg; 2016 Apr; 88():631-639. PubMed ID: 26578351
[TBL] [Abstract][Full Text] [Related]
2. Could propranolol be beneficial in adult cerebral cavernous malformations?
Apra C; Dumot C; Bourdillon P; Pelissou-Guyotat I
Neurosurg Rev; 2019 Jun; 42(2):403-408. PubMed ID: 30610500
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial.
Lanfranconi S; Scola E; Meessen JMTA; Pallini R; Bertani GA; Al-Shahi Salman R; Dejana E; Latini R;
Lancet Neurol; 2023 Jan; 22(1):35-44. PubMed ID: 36403580
[TBL] [Abstract][Full Text] [Related]
4. Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial.
Lanfranconi S; Scola E; Bertani GA; Zarino B; Pallini R; d'Alessandris G; Mazzon E; Marino S; Carriero MR; Scelzo E; Faragò G; Castori M; Fusco C; Petracca A; d'Agruma L; Tassi L; d'Orio P; Lampugnani MG; Nicolis EB; Vasamì A; Novelli D; Torri V; Meessen JMTA; Al-Shahi Salman R; Dejana E; Latini R;
Trials; 2020 May; 21(1):401. PubMed ID: 32398113
[TBL] [Abstract][Full Text] [Related]
5. Medullary hemorrhage that preceded the onset of multiple cavernous angiomas.
Naoi T; Nakao K; Nakamura Y; Ando A; Kawakami T
Intern Med; 2015; 54(7):843-6. PubMed ID: 25832954
[TBL] [Abstract][Full Text] [Related]
6. Propranolol for cerebral cavernous angiomatosis: a magic bullet.
Berti I; Marchetti F; Skabar A; Zennaro F; Zanon D; Ventura A
Clin Pediatr (Phila); 2014 Feb; 53(2):189-90. PubMed ID: 23804539
[No Abstract] [Full Text] [Related]
7. Natural history of cerebral cavernous malformations.
Ene C; Kaul A; Kim L
Handb Clin Neurol; 2017; 143():227-232. PubMed ID: 28552144
[TBL] [Abstract][Full Text] [Related]
8. In Reply to the Letter to the Editor Regarding "Propranolol Treatment of Cavernous Malformations with Symptomatic Hemorrhage".
Zabramski JM
World Neurosurg; 2021 Jan; 145():513. PubMed ID: 33348494
[No Abstract] [Full Text] [Related]
9. Cerebral Cavernous Malformations, Developmental Venous Anomaly, and Its Coexistence: A Review.
Idiculla PS; Gurala D; Philipose J; Rajdev K; Patibandla P
Eur Neurol; 2020; 83(4):360-368. PubMed ID: 32731220
[TBL] [Abstract][Full Text] [Related]
10. Association Between Beta-Blocker or Statin Drug Use and the Risk of Hemorrhage From Cerebral Cavernous Malformations.
Zuurbier SM; Hickman CR; Rinkel LA; Berg R; Sure U; Al-Shahi Salman R;
Stroke; 2022 Aug; 53(8):2521-2527. PubMed ID: 35410492
[TBL] [Abstract][Full Text] [Related]
11. Clinical course of untreated thalamic cavernous malformations: hemorrhage risk and neurological outcomes.
Tian KB; Zheng JJ; Ma JP; Hao SY; Wang L; Zhang LW; Wu Z; Zhang JT; Li D
J Neurosurg; 2017 Sep; 127(3):480-491. PubMed ID: 27834594
[TBL] [Abstract][Full Text] [Related]
12. Hypertrophic olivary degeneration following pontine cavernoma hemorrhage: a typical change accompanying lesions in the Guillain-Mollaret triangle.
Macht S; Hänggi D; Turowski B
Klin Neuroradiol; 2009 Aug; 19(3):235-7. PubMed ID: 19727585
[No Abstract] [Full Text] [Related]
13. Predictors of Initial Presentation with Hemorrhage in Patients with Cavernous Malformations.
Flemming KD; Kumar S; Brown RD; Lanzino G
World Neurosurg; 2020 Jan; 133():e767-e773. PubMed ID: 31605843
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of multifocal intracerebral and spinal hemangiomas with propranolol.
Miquel J; Bruneau B; Dupuy A
J Am Acad Dermatol; 2014 Apr; 70(4):e83-e84. PubMed ID: 24629368
[No Abstract] [Full Text] [Related]
15. Giant cavernous malformation of the occipital lobe.
Chicani CF; Miller NR; Tamargo RJ
J Neuroophthalmol; 2003 Jun; 23(2):151-3. PubMed ID: 12782930
[TBL] [Abstract][Full Text] [Related]
16. Prospective Hemorrhage Rates of Cerebral Cavernous Malformations in Children and Adolescents Based on MRI Appearance.
Nikoubashman O; Di Rocco F; Davagnanam I; Mankad K; Zerah M; Wiesmann M
AJNR Am J Neuroradiol; 2015 Nov; 36(11):2177-83. PubMed ID: 26272978
[TBL] [Abstract][Full Text] [Related]
17. The prospective natural history of cerebral venous malformations.
McLaughlin MR; Kondziolka D; Flickinger JC; Lunsford S; Lunsford LD
Neurosurgery; 1998 Aug; 43(2):195-200; discussion 200-1. PubMed ID: 9696070
[TBL] [Abstract][Full Text] [Related]
18. Long-term natural history of incidentally discovered cavernous malformations in a single-center cohort.
Moore SA; Brown RD; Christianson TJ; Flemming KD
J Neurosurg; 2014 May; 120(5):1188-92. PubMed ID: 24628608
[TBL] [Abstract][Full Text] [Related]
19. Hemorrhage owing to cerebral cavernous malformation: imaging, clinical, and histopathological considerations.
Kurihara N; Suzuki H; Kato Y; Rikimaru H; Sato A; Uenohara H
Jpn J Radiol; 2020 Jul; 38(7):613-621. PubMed ID: 32221793
[TBL] [Abstract][Full Text] [Related]
20. Brainstem cavernous malformations: anatomical, clinical, and surgical considerations.
Giliberto G; Lanzino DJ; Diehn FE; Factor D; Flemming KD; Lanzino G
Neurosurg Focus; 2010 Sep; 29(3):E9. PubMed ID: 20809767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
